Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Investigating Adherence to Cereneo Tele-service Support After Clinical Disharge in Stroke Patients

27. Januar 2021 aktualisiert von: Cereneo AG

Investigating Adherence to Cereneo Tele-service Support After Clinical Disharge in Stroke Patients- Observational, Pilot Study

This observational, prospective cohort, pilot study aims at investigating usability, operational, and economical factors around 'traditional' and 'technology-supported' approaches to promote a healthy life-style in stroke survivors, after discharge from an in-patient clinic.

The investigators primary objective is to evaluate the adherence to prescribed behavioral changes in dieting and exercising up to one year after clinical discharge. This pilot study will follow and document the observations of two groups of patients, one offered a 'traditional' and another one a 'technology-supported' approach by the healthcare provider.

The investigators secondary objective is to gain insights on how to efficiently (and securely) facilitate remote counselling once patients get discharged from the clinic.

Studienübersicht

Status

Beendet

Intervention / Behandlung

Detaillierte Beschreibung

The investigators will screen and randomize hospitalized patients at the cereneo Schweiz AG - center for neurology & rehabilitation.

The participant will be informed that his/her medical records may be examined by authorized individuals other than their treating physician.

All participants for the study will be provided a participant information sheet and a consent form describing the study and providing enough information for participant to make an informed decision about their participation in the study. Patients will be given at least one day to make their decision. The formal consent of a participant, using the approved consent form, will be obtained before the participant is submitted to any study procedure.

The process from the admission to an in-patient clinic to home discharge will follow the routine procedures at the cereneo clinic.

During the clinical stay, non-modifiable (e.g. age, gender) and modifiable risk factors (e.g. blood values, blood pressure, diabetes) for stroke are assessed by an interdisciplinary team of health care providers . For present risk factors, causes among behavioral and psychosocial factors are investigated and possible behavioral changes are estimated.

The clinical team provides information and education during in-clinic consultations.

This study will pay particular attention to the counselling sessions related to exercising and dieting.

In terms of dieting a nutrition specialist helps patients create a personal plan to meet their needs. Food and nutritional care quality is assessed weekly and scored, so as to improve health institution efficacy in patient assistance. In-depth nutrition assessments may include evaluation of anthropometric, biochemical, and clinical data; evaluation of energy and nutrient intake at home or in the hospital; evaluation of access to food at home; calculation or measurement of energy and nutrient needs; and assessment of educational demand. All of this is done within the context of the patient's history of the present illness and treatments received. Within this phase, patients may be prescribed with special diets that are modified in macro- or micronutrients, consistency, nutrient or energy supplementation using liquid dietary supplements, vitamin and mineral supplements, enteral or parenteral nutrition support, or nutrition counselling.

In terms of exercising, movement therapists are assessing the patient's performance weekly and discuss possibilities for self-training homework exercises, considering the patient's health status and short-term therapy goals. Therapy exercises might be described on paper or video-taped for further independent training. Recommended activities might be conducted independently or with the help of the care team between therapy sessions.

Prior to discharge, a session between the medical team and the patient and his/her relatives (or main caregiver) is organized. Within such sessions, individual advices with respect to behavioral changes at home are discussed.

Individual goals including, but not limited to, exercising and dieting are discussed and set. General educational material including general guidelines in alcohol and tobacco consummation, overall activity, and general dietary recommendations are typically printed on paper and handed over to the patient.

After clinic discharge, it is understood that the in-patient clinic is no longer the main responsible for the patient maintaining a healthy lifestyle.

In this study, the investigators will provide (within the context of this study) additional medical support or tele-service, at no cost to the participants.

The Investigators will provide follow-ups video-calls and visits at predetermined timepoints, at no cost to the participants.

Two different service approaches will be investigated. One approach consists of a 'Traditional' approach, in which the healthcare provider (cereneo clinic) relies on traditional tools to provide a service (use of Electronic Medical Records, prescription of diet and exercising given on a piece of paper/or by in-person debriefing, phone calls, etc.). The second approach, 'Technology-supported', consists on the same approach, but with the aid of new technological tools (e.g. video-conference, exercise prescription and meal planner programs, activity tracking, etc.) to provide a better service to the patient.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

2

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Lucern
      • Vitznau, Lucern, Schweiz, 6354
        • cereneo Schweiz AG | center for neurology & rehabilitation

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Kind
  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Wahrscheinlichkeitsstichprobe

Studienpopulation

20 stroke patients

Beschreibung

Inclusion criteria

  • Male or Female individuals above ≥ 18 years of age;
  • established diagnosis of the specific pathological condition - stroke
  • planned to be discharged from in-patient setting to their home
  • ability to give informed consent
  • can communicate in German, Italian or English

Exclusion criteria:

  • are not medically stable (determined by the treating medical doctor)
  • cognitive disabilities as defined by MoCa < 20
  • have aphasia, dysarthria, apraxia or neglect and/or hemianopsia preventing them from conducting examinations, using tablet devices and/or receiving educational counselling
  • have dysphagia which requires close medical care
  • have clinically important musculoskeletal or other neurological conditions preventing them from using a tablet device
  • terminal condition
  • Strong resistance towards risk factor education and nutritional guidance
  • no internet connection or telephone line and reachable internet provider at home
  • Social or personal circumstance, which interfere with the participation of the study

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: Kohorte
  • Zeitperspektiven: Interessent

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
'Traditional' group
10 stroke patients
behavioral changes in dieting and exercising up to one year after clinical discharge
'Technology-supported' group
10 stroke patients
behavioral changes in dieting and exercising up to one year after clinical discharge

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Adherence to prescribed dieting
Zeitfenster: 12 months
Goal Attainment Scaling in Rehabilitation test
12 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Krizia Ferrini, PhD, cereneo Schweiz AG | center for neurology & rehabilitation

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

11. Juli 2019

Primärer Abschluss (Tatsächlich)

11. August 2020

Studienabschluss (Tatsächlich)

11. August 2020

Studienanmeldedaten

Zuerst eingereicht

12. September 2019

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

27. Januar 2021

Zuerst gepostet (Tatsächlich)

2. Februar 2021

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

2. Februar 2021

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

27. Januar 2021

Zuletzt verifiziert

1. Januar 2021

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

Ja

Beschreibung des IPD-Plans

All data not recorded on the CRF will be stored in a database or locally on the computers of different training devices or online if the device offers online processing. The link between the online processed data and the respective patient's identity is only known to authorized therapeutic personnel.

All data not in the CRF is not study specific and is routinely recoded. The used database is embedded into the clinics patient administration system called Vitomed.

The training devices record training data and store the data locally or online. Selected data of the devices relevant to the study will be copied and stored to the mentioned database or to the CRF if study specific, respectively.

All the data storing systems besides the CRF are routinely used within the clinic.

IPD-Sharing-Zeitrahmen

All study data will be archived for a minimum of 10 years after study termination or premature termination of the study. Biological material in this project is not identified by participant name but by a unique participant number. Biological material will be sent abroad in the scope of the research project, if the participant involved has given his/her consent to do so upon having been sufficiently informed (HRO, Section 2).

The original medical records in the eKardex of cereneo are subject to the data protection policy of the informatics division of the clinic.

The paper CRFs as well as the printouts of the interim data analysis results in Excel™, SPSS™, Matlab™ (or similar software) will be stored in a locked archive room of the cereneo center for neurology and rehabilitation.

IPD-Sharing-Zugriffskriterien

The CRF will be kept in a locked deposit in the study site. Only authorized personnel by the study will have access.

The database of the clinics administration software can only be accessed by authorized therapeutic and administrational staff of the clinic. Only the clinics IT administrators have access to the database backups and change logs.

Anthropometric assessments and nutrition status data, usability test of the application , satisfaction test of the log of meal planning app (provided by the AAL LIFANA project) will be compiled into a master file and pseudonymized. This anonymized and coded data within the master file will be shared with the Luxemburg Institute of Health (LIH) and Luxemburg Institute of Science and Technology (LIST) for statistical evaluation and interpretation, as part of the AAL LIFANA (Lifelong Food and Nutrition Assistance) project, which partially sponsors this study.

Art der unterstützenden IPD-Freigabeinformationen

  • Statistischer Analyseplan (SAP)

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Produkt, das in den USA hergestellt und aus den USA exportiert wird

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Secondary Prevention

3
Abonnieren